Spanish pharmaceutical company PharmaMar said this morning the peer review journal Science has published a paper that confirms its drug Plitidepsin has a "potent preclinical efficacy" against the COVID-19.
Coronavirus news
Science Magazine confirms efficacy of Spain´s PharmaMar's Plitidepsin against COVID-19
"Should be strongly considered for expanded clinical trials for the treatment of COVID-19"
Also in News
- What a carry on! European Union abandons full launch of new travel entry system for Britons in favour of "phased rollout"
- Uncertainty surrounds EU Entry/Exit System implementation
- Fresh hope for Golden Visa in Spain
- Living in Palma Airport - Safe and warm
- Laura Hamilton: “I’ve always loved Mallorca, I just wished I’d bought here earlier...”
No comments
To be able to write a comment, you have to be registered and logged in
Currently there are no comments.